Pfizer Sales Manager Gets Probation for Deleting Bextra Off-Label Data
Executive Summary
A Pfizer sales manager was sentenced July 16 to six months of home confinement with electronic monitoring and three years of probation for obstruction of justice in the government's investigation of off-label promotion of Bextra (valdecoxib)
You may also be interested in...
Former Purdue Execs Fight Exclusion From Gov't Programs After OxyContin Case
The three former Purdue Pharma executives who pled guilty to misbranding OxyContin are battling the government for the ability to work in the health care sector. They have sued HHS for barring them from participation in government health programs for 12 years
Pfizer's Record-Breaking $2.3 Bil. Settlement With U.S. Attorney Imposes New Restrictions on Corporate Behavior
Pfizer's $2.3 billion settlement with the U.S. Department of Justice is unprecedented in size and scope, resolving allegations of off-label marketing of four drugs and kickbacks to health care providers involving nine other drugs. Moreover, the deal includes the largest criminal fine ever imposed by the U.S. government in any matter
Pfizer's Record-Breaking $2.3 Bil. Settlement With U.S. Attorney Imposes New Restrictions on Corporate Behavior
Pfizer's $2.3 billion settlement with the U.S. Department of Justice is unprecedented in size and scope, resolving allegations of off-label marketing of four drugs and kickbacks to health care providers involving nine other drugs. Moreover, the deal includes the largest criminal fine ever imposed by the U.S. government in any matter